期刊文献+

雌激素β受体对子宫内膜异位症形成的影响 被引量:4

Effect of estrogen receptor β on the formation of mice endometriosis
下载PDF
导出
摘要 目的探讨雌激素β受体(ER-β)对子宫内膜异位症形成的影响。方法采用30只ER-β基因敲除(βERKO)小鼠及22只同源未敲除(βER)小鼠建立子宫内膜异位症模型。将两种小鼠各分为3组:保留卵巢组(βERKO10只、βER8只)、切除卵巢组(βERKO10只、βER7只)、切除卵巢+雌激素组(βERKO10只、βER7只)。术后2周分别取出两种小鼠的子宫内膜异位灶,检测其重量、组织形态、MMP-9的蛋白含量,并进行比较分析。结果术后2周保留卵巢组移植物重量明显高于术前(P<0.05),切除卵巢+雌激素组手术前后移植物重量无明显差异(P>0.05),而切除卵巢组术后移植物重量明显低于术前(P<0.05);但βERKO与βER两种小鼠间移植物重量无明显差异(P>0.05)。βERKO与βER两种小鼠异位病灶的组织形态及各部位的MMP-9表达也无显著差异(P>0.05)。结论ER-β对子宫内膜异位症的形成影响微弱。 Objective To investigate the effect of estrogen receptor β (ER-β) on the formation of mice endometriosis. Methods Endometriosis animal model was established with 30 ERβ knockout (βERKO) mice and 22 ER-β non-knockout (βER) mice. All the mice were divided into three groups: intact group (βERKO 10 and βER 8), ovariectomy group (βERKO 10 and βER 7) and ovariectomy estradiol treatment group (βERKO 10 and βER 7). The endometriotic grafts were taken out from all the mice 2 weeks after operation, and the weight, histological structure and the expression of MMP9 in the grafts were analyzed and compared between βERKO and βER mice. Results The endometriotic grafts were significantly heavier 2 weeks after transplantation than that before transplantation in intact group (P〈0. 05), and were lighter than that before transplantation in ovariectomy group (P〈0. 05), but no significant difference was found before and 2 weeks after transplantation in ovariectomy + estradiol treatment group (P〉0. 05). In addition, no significant differences were found between the βERKO and the βER mice in endometriotic grafts' weight, the histopathologic structure and the expression of MMP-9. Conclusion ER may throw few influence on the formation of endometriosis.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2009年第8期983-985,共3页 Medical Journal of Chinese People's Liberation Army
基金 科技部科技攻关计划课题资助项目(2004BA720A07-02)
关键词 小鼠 基因敲除 雌激素受体Β 子宫内膜异位症 mice, knockout estrogen receptor beta endometriosis
  • 相关文献

参考文献2

二级参考文献12

  • 1付生法,陆应麟,张朝山,陈坤.检测血管生长因子作用的鸡胚绒毛尿囊膜技术[J].军事医学科学院院刊,1993,17(4):294-297. 被引量:129
  • 2Inan S,Kuscu NK,Vatansever S et al.Increased vascular surface density in ovarian endometriosis.Gynecol Endocrinol,2003,17(2):143
  • 3Ota H,Tanaka T.Stromal vascularization in the endomeiosis during adenomyosis.Microsc Res Tech,2003,60(4):45
  • 4Taylor RN,Lebovic DI,Mueller MD.Angiogenic factors in endometriosis.Ann N Y Acad Sci,2002,955:89
  • 5Taylor RN,Lebovic DI,Hornung D et al.Endocrine and paracrine regulation of endometrial angiogenesis.Ann N Y Acad Sci,2001,943:109
  • 6Gasparini G,Longo R,Fandlli M et al.Combination of antiangiogenic therapy with other anticancer therapies:results,challenges,and open questions.J Clin Oncol,2005,23(6):1295
  • 7Fraser HM,Lurn SF.Angiogenesis and its control in the female reproductive system.Br Med Bull,2000,56(3):789
  • 8Nap AW,Griffioen AW,Dunselman GA et al.Antiangiogenesis therapy for endometriosis.J Clin Endocrinol Metab,2004,89(3):1089
  • 9Hull ML,Charnock-Jones DS,Chan CL et al.Antiangiogenic agents are effective inhibitors of endometriosis.J Clin Endocrinol Metab,2003,88(6):2889
  • 10Kim YM,Jang JW,Lee OH et al.Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation snd catalytic activity of matrix metalloproteinase 2.Cancer Res,2000,60(19):5410

共引文献8

同被引文献57

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部